"Good candidates are individuals who are identified as having cognitive impairment distinct from normal aging via abnormal ...

Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. The best way to use the test, however, is unclear.

These Alzheimer's tests raise many important issues that patients and their physicians should carefully consider before ...

Researchers have developed and validated a simple “peel-and-sniff” test that can be completed unsupervised at home to screen for cognitive impairment. It’s well known that impaired olfactory function ...

In a new study, elevated blood markers of Alzheimer’s disease in healthy adults were tied to future risk of cognitive issues. But the test isn’t ready for widespread use just yet. A blood test ...

Voice AI cognitive screening can now detect signs of dementia from ordinary conversation, with no clinical task required. A ...

A cognitive test is a required part of the Medicare annual wellness visit (AWV). This can be a valuable tool in discovering specific cognitive health conditions early, like dementia and Alzheimer’s ...

Just like we do for our hearts and our bodies, we need to have a multimodal approach to risk reduction of brain disease.” ...

"These blood tests should really be reserved for people who are at risk or are having early symptoms of memory issues." ...

You’ve forgotten a few appointments lately and you find yourself losing track of conversations. Close friends or family may have also noticed some changes in your memory or thinking. Becoming more ...

Researchers found that a blood test measuring the biomarker p-tau217 helped estimate the likelihood of developing cognitive impairment over the next five t ...

Medical experts have said they believe that President Donald Trump recently took the Montreal Cognitive Assessment. It is designed to detect cognitive impairment, not intelligence. Trump said he ...